{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/110622"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/110622","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Developing a biomaterial model of the glioblastoma perivascular niche to investigate the effects of angiocrine signals on disease progression","abstract":"Brain and other central nervous system cancers affect tens of thousands of people every year and remain a challenging class of diseases to treat. Glioblastoma (GBM) is the most common primary malignant form of brain cancer and accounts for nearly 50% of all malignant brain tumors. Prognosis for GBM is grim, as the median survival time is approximately 15 months and the five-year survival rate is 10%. The challenge in treating GBM is a product of intratumoral heterogeneity and a pro-tumorigenic microenvironment. Specifically, the perivascular niche (PVN) of GBM has been shown to facilitate tumor cell invasion and harbor a subpopulation of cancer stem cells, which are implicated in tumorigenesis and disease recurrence. However, the mechanisms by which the PVN promotes disease progression are unclear. Angiocrine cues are signals derived from vascular cells and have been shown to influence tumor cell behavior in metastatic cancers. Identifying angiocrine cues in GBM will provide an improved understanding of how the microenvironment contributes to disease progression and enable the development of new therapeutics. Currently, in vitro platforms that recapitulate the architecture and cellular interactions found in the in-vivo PVN are lacking and limit the exploration and discovery of angiocrine cues. Thus, this dissertation focuses on the development of biomaterial platforms to recapitulate the tumor-vascular cellular interactions that occur in GBM, as well as the utilization of these platforms to identify the effects of angiocrine signals on tumor cell behavior and potential mechanisms of tumor cell infiltration and therapeutic resistance. We establish design principles for developing vascularized tumor models in gelatin hydrogels and workflows for evaluating heterotypic cell-cell interactions. Furthermore, we demonstrate the ability to establish and utilized vascularized biomaterial platforms to investigate the role of angiocrine cues beyond tumor biology. Collectively, the work in this dissertation provides a methodology for developing physiologically relevant benchtop models of perivascular niche environments to investigate the role of angiocrine cues in homeostasis, regeneration, and disease.","abstract_html":"Brain and other central nervous system cancers affect tens of thousands of people every year and remain a challenging class of diseases to treat. Glioblastoma (GBM) is the most common primary malignant form of brain cancer and accounts for nearly 50% of all malignant brain tumors. Prognosis for GBM is grim, as the median survival time is approximately 15 months and the five-year survival rate is 10%. The challenge in treating GBM is a product of intratumoral heterogeneity and a pro-tumorigenic microenvironment. Specifically, the perivascular niche (PVN) of GBM has been shown to facilitate tumor cell invasion and harbor a subpopulation of cancer stem cells, which are implicated in tumorigenesis and disease recurrence. However, the mechanisms by which the PVN promotes disease progression are unclear. Angiocrine cues are signals derived from vascular cells and have been shown to influence tumor cell behavior in metastatic cancers. Identifying angiocrine cues in GBM will provide an improved understanding of how the microenvironment contributes to disease progression and enable the development of new therapeutics. Currently, in vitro platforms that recapitulate the architecture and cellular interactions found in the in-vivo PVN are lacking and limit the exploration and discovery of angiocrine cues. Thus, this dissertation focuses on the development of biomaterial platforms to recapitulate the tumor-vascular cellular interactions that occur in GBM, as well as the utilization of these platforms to identify the effects of angiocrine signals on tumor cell behavior and potential mechanisms of tumor cell infiltration and therapeutic resistance. We establish design principles for developing vascularized tumor models in gelatin hydrogels and workflows for evaluating heterotypic cell-cell interactions. Furthermore, we demonstrate the ability to establish and utilized vascularized biomaterial platforms to investigate the role of angiocrine cues beyond tumor biology. Collectively, the work in this dissertation provides a methodology for developing physiologically relevant benchtop models of perivascular niche environments to investigate the role of angiocrine cues in homeostasis, regeneration, and disease.","abstract_has_math":false,"creators":["Ngo, Mai T."],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Chemical Engineering","degree_department":null,"school":null,"contributors":["Harley, Brendan AC","Bhargava, Rohit","Kong, Hyunjoon","Gaskins, H. Rex"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-09-17T02:34:11Z","date_published":"2021-09-17T02:34:11Z","updated_at":"2026-07-22T22:24:52Z","subjects":["biomaterials","tissue engineering","cancer","glioblastoma","vascularization","angiogenesis","angiocrine"],"languages":["en"],"rights":["Copyright 2021 Mai Ngo"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/110622","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Harley, Brendan AC","Bhargava, Rohit","Kong, Hyunjoon","Gaskins, H. Rex"]},{"key":"dc:creator","label":"Author","values":["Ngo, Mai T."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-09-17T02:34:11Z","2023-09-17T02:34:57Z","2021-01-07","2021-05"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["biomaterials","tissue engineering","cancer","glioblastoma","vascularization","angiogenesis","angiocrine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2021 Mai Ngo"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/110622"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Brain and other central nervous system cancers affect tens of thousands of people every year and remain a challenging class of diseases to treat. Glioblastoma (GBM) is the most common primary malignant form of brain cancer and accounts for nearly 50% of all malignant brain tumors. Prognosis for GBM is grim, as the median survival time is approximately 15 months and the five-year survival rate is 10%. The challenge in treating GBM is a product of intratumoral heterogeneity and a pro-tumorigenic microenvironment. Specifically, the perivascular niche (PVN) of GBM has been shown to facilitate tumor cell invasion and harbor a subpopulation of cancer stem cells, which are implicated in tumorigenesis and disease recurrence. However, the mechanisms by which the PVN promotes disease progression are unclear. Angiocrine cues are signals derived from vascular cells and have been shown to influence tumor cell behavior in metastatic cancers. Identifying angiocrine cues in GBM will provide an improved understanding of how the microenvironment contributes to disease progression and enable the development of new therapeutics. Currently, in vitro platforms that recapitulate the architecture and cellular interactions found in the in-vivo PVN are lacking and limit the exploration and discovery of angiocrine cues. Thus, this dissertation focuses on the development of biomaterial platforms to recapitulate the tumor-vascular cellular interactions that occur in GBM, as well as the utilization of these platforms to identify the effects of angiocrine signals on tumor cell behavior and potential mechanisms of tumor cell infiltration and therapeutic resistance. We establish design principles for developing vascularized tumor models in gelatin hydrogels and workflows for evaluating heterotypic cell-cell interactions. Furthermore, we demonstrate the ability to establish and utilized vascularized biomaterial platforms to investigate the role of angiocrine cues beyond tumor biology. Collectively, the work in this dissertation provides a methodology for developing physiologically relevant benchtop models of perivascular niche environments to investigate the role of angiocrine cues in homeostasis, regeneration, and disease.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2023-05-01","The student, Mai Ngo, accepted the attached license on 2021-01-04 at 21:53.","The student, Mai Ngo, submitted this Dissertation for approval on 2021-01-04 at 22:02.","This Dissertation was approved for publication on 2021-01-07 at 10:48.","DSpace SAF Submission Ingestion Package generated from Vireo submission #16142 on 2021-09-16 at 17:01:34","Made available in DSpace on 2021-09-17T02:34:11Z (GMT). No. of bitstreams: 4 NGO-DISSERTATION-2021.pdf: 6818221 bytes, checksum: dd7a1b421f025674d0bed7b1bd04445a (MD5) Ngo_Thesis_Compiled_FINAL.docx: 25866983 bytes, checksum: d76cb850f7ed0d591e8d3e2fd5348454 (MD5) LICENSE.txt: 4204 bytes, checksum: ce2a5db335188779d92d7436983a72a2 (MD5) PROQUEST_LICENSE.txt: 4550 bytes, checksum: e73bf328fba4a0fa63cd6017586be0f6 (MD5) Previous issue date: 2021-01-07","Embargo set by: Seth Robbins for item 118465 Lift date: 2023-09-17T02:34:57Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Developing a biomaterial model of the glioblastoma perivascular niche to investigate the effects of angiocrine signals on disease progression"]}]}],"canonical_facts":{"dc:contributor":["Harley, Brendan AC","Bhargava, Rohit","Kong, Hyunjoon","Gaskins, H. Rex"],"dc:creator":["Ngo, Mai T."],"dc:date":["2021-09-17T02:34:11Z","2023-09-17T02:34:57Z","2021-01-07","2021-05"],"dc:description":["Brain and other central nervous system cancers affect tens of thousands of people every year and remain a challenging class of diseases to treat. Glioblastoma (GBM) is the most common primary malignant form of brain cancer and accounts for nearly 50% of all malignant brain tumors. Prognosis for GBM is grim, as the median survival time is approximately 15 months and the five-year survival rate is 10%. The challenge in treating GBM is a product of intratumoral heterogeneity and a pro-tumorigenic microenvironment. Specifically, the perivascular niche (PVN) of GBM has been shown to facilitate tumor cell invasion and harbor a subpopulation of cancer stem cells, which are implicated in tumorigenesis and disease recurrence. However, the mechanisms by which the PVN promotes disease progression are unclear. Angiocrine cues are signals derived from vascular cells and have been shown to influence tumor cell behavior in metastatic cancers. Identifying angiocrine cues in GBM will provide an improved understanding of how the microenvironment contributes to disease progression and enable the development of new therapeutics. Currently, in vitro platforms that recapitulate the architecture and cellular interactions found in the in-vivo PVN are lacking and limit the exploration and discovery of angiocrine cues. Thus, this dissertation focuses on the development of biomaterial platforms to recapitulate the tumor-vascular cellular interactions that occur in GBM, as well as the utilization of these platforms to identify the effects of angiocrine signals on tumor cell behavior and potential mechanisms of tumor cell infiltration and therapeutic resistance. We establish design principles for developing vascularized tumor models in gelatin hydrogels and workflows for evaluating heterotypic cell-cell interactions. Furthermore, we demonstrate the ability to establish and utilized vascularized biomaterial platforms to investigate the role of angiocrine cues beyond tumor biology. Collectively, the work in this dissertation provides a methodology for developing physiologically relevant benchtop models of perivascular niche environments to investigate the role of angiocrine cues in homeostasis, regeneration, and disease.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2023-05-01","The student, Mai Ngo, accepted the attached license on 2021-01-04 at 21:53.","The student, Mai Ngo, submitted this Dissertation for approval on 2021-01-04 at 22:02.","This Dissertation was approved for publication on 2021-01-07 at 10:48.","DSpace SAF Submission Ingestion Package generated from Vireo submission #16142 on 2021-09-16 at 17:01:34","Made available in DSpace on 2021-09-17T02:34:11Z (GMT). No. of bitstreams: 4 NGO-DISSERTATION-2021.pdf: 6818221 bytes, checksum: dd7a1b421f025674d0bed7b1bd04445a (MD5) Ngo_Thesis_Compiled_FINAL.docx: 25866983 bytes, checksum: d76cb850f7ed0d591e8d3e2fd5348454 (MD5) LICENSE.txt: 4204 bytes, checksum: ce2a5db335188779d92d7436983a72a2 (MD5) PROQUEST_LICENSE.txt: 4550 bytes, checksum: e73bf328fba4a0fa63cd6017586be0f6 (MD5) Previous issue date: 2021-01-07","Embargo set by: Seth Robbins for item 118465 Lift date: 2023-09-17T02:34:57Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/110622"],"dc:language":["en"],"dc:rights":["Copyright 2021 Mai Ngo"],"dc:subject":["biomaterials","tissue engineering","cancer","glioblastoma","vascularization","angiogenesis","angiocrine"],"dc:title":["Developing a biomaterial model of the glioblastoma perivascular niche to investigate the effects of angiocrine signals on disease progression"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Chemical Engineering"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:52Z"}